263 related articles for article (PubMed ID: 20133281)
1. Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation.
Petrakis I; Stylianou K; Mavroeidi V; Vardaki E; Stratigis S; Stratakis S; Xylouri I; Perakis C; Petraki C; Nakopoulou L; Daphnis E
Nephrol Dial Transplant; 2010 Jun; 25(6):2020-3. PubMed ID: 20133281
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
3. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation.
Weichman K; Dember LM; Prokaeva T; Wright DG; Quillen K; Rosenzweig M; Skinner M; Seldin DC; Sanchorawala V
Bone Marrow Transplant; 2006 Sep; 38(5):339-43. PubMed ID: 16862166
[TBL] [Abstract][Full Text] [Related]
5. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
[TBL] [Abstract][Full Text] [Related]
6. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
7. Resolution of mesangial light chain deposits 3 years after high-dose melphalan with autologous peripheral blood stem cell transplantation.
Harada K; Akai Y; Sakan H; Yamaguchi Y; Nakatani K; Iwano M; Saito Y
Clin Nephrol; 2010 Nov; 74(5):384-8. PubMed ID: 20979947
[TBL] [Abstract][Full Text] [Related]
8. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
[TBL] [Abstract][Full Text] [Related]
9. [Light chain deposition disease. Experience in our environment].
Martín Herrera C; Suñer Poblet M; Cabrera R; Díaz Pedrero M; Fernández Alonso J
Nefrologia; 2008; 28(5):539-42. PubMed ID: 18816213
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary manifestations of light chain deposition disease.
Rho L; Qiu L; Strauchen JA; Gordon RE; Teirstein AS
Respirology; 2009 Jul; 14(5):767-70. PubMed ID: 19659654
[TBL] [Abstract][Full Text] [Related]
11. [Kidney involvement in light-chain deposition disease].
Merta M; Rysavá R; Zabka J; Stejskalová A; Vernerová Z; Haber J; Spicka I; Tesar V; Klener P
Sb Lek; 2002; 103(3):397-403. PubMed ID: 12688183
[TBL] [Abstract][Full Text] [Related]
12. Lambda light chain deposition disease in a renal allograft.
Tanenbaum ND; Howell DN; Middleton JP; Spurney RF
Transplant Proc; 2005 Dec; 37(10):4289-92. PubMed ID: 16387099
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab?
Kuypers DR; Lerut E; Claes K; Evenepoel P; Vanrenterghem Y
Transpl Int; 2007 Apr; 20(4):381-5. PubMed ID: 17326779
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
Ronco P; Plaisier E; Mougenot B; Aucouturier P
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
[TBL] [Abstract][Full Text] [Related]
15. Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation.
Firkin F; Hill PA; Dwyer K; Gock H
Am J Kidney Dis; 2004 Sep; 44(3):551-5. PubMed ID: 15332228
[TBL] [Abstract][Full Text] [Related]
16. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.
Kaposztas Z; Kahan BD; Katz SM; Van Buren CT; Cherem L
Transplant Proc; 2009 Dec; 41(10):4407-10. PubMed ID: 20005409
[TBL] [Abstract][Full Text] [Related]
18. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition.
Sanders PW; Herrera GA; Kirk KA; Old CW; Galla JH
Lab Invest; 1991 Apr; 64(4):527-37. PubMed ID: 1901926
[TBL] [Abstract][Full Text] [Related]
20. Kidney and liver involvement in monoclonal light chain disorders.
Pozzi C; Locatelli F
Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
